KIT and gastrointestinal stromal tumor: Activation of VEGF/VEGFR signaling in IM-resistant GIST cells might be a result of FGF2 production by KIT-inhibited cancer cells, which in turn leads to the production and secretion of VEGF-A, and thereby activates VEGFR-mediated cascade.